[1]
Ballas SK, Bauserman RL, McCarthy WF, Castro OL, Smith WR, Waclawiwa MA. Investigators of the multicenter study of hydroxyurea in sickle cell, utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: effect ofsex, age, and geographical location. Am J Hematol 2010;85:613–6.CrossrefGoogle Scholar
[2]
Dampier C, Ely B, Brodecki D, O’Neal P. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain 2002;3:461–70.PubMedCrossrefGoogle Scholar
[3]
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, Aisiku IP, Levenson JL, Roseff SD. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008;148:94–101.PubMedCrossrefGoogle Scholar
[4]
Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease.Rates and risk factors. N Engl J Med 1991;325:11-6.CrossrefPubMedGoogle Scholar
[5]
Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, Sable C, Ensing G, Dham N, Campbell A, Arteta M, Gladwin MT, Castro O, Taylor JGT, Kato GJ, Gordeuk V. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 2012;160:286–90.CrossrefPubMedGoogle Scholar
[6]
Shapiro BS, Dinges DF, Orne EC, Bauer N, Reilly LB, Whitehouse WG, Ohene-Frempong K, Orne MT. Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain 1995;61:139–44.PubMedCrossrefGoogle Scholar
[7]
Zempsky WT, O’Hara EA, Santanelli JP, Palermo TM, New T, Smith-Whitley K, Casella JF. Validation of the sickle cell disease pain burden interview-youth. J Pain 2013;14:975–82.PubMedCrossrefGoogle Scholar
[8]
Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Angulo V, Wilkie DJ. Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease. J Pain Symptom Manag 2014;48:65–74.CrossrefGoogle Scholar
[9]
Dampier C, Palermo TM, Darbari DS, Hassell K, Smith W, Zempsky W. AAPT diagnostic criteria forchronic sickle cell disease pain. J Pain 2017.Google Scholar
[10]
Darbari DS, Ballas SK, Clauw DJ. Thinking beyond sickling to better understand pain in sickle cell disease. EurJ Haematol 2014;93:89–95.CrossrefGoogle Scholar
[11]
Belfer I, Youngblood V, Darbari DS, Wang Z, Diaw L, Freeman L, Desai K, Dizon M, Allen D, Cunnington C, Channon KM, Milton J, Hartley SW, Nolan V, Kato GJ, Steinberg MH, Goldman D, Taylor JGT. A GCHl haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia. AmJ Hematol 2014;89:187–93.CrossrefGoogle Scholar
[12]
Kohli DR, Li Y, Khasabov SG, Gupta P, Kehl LJ, Ericson ME, Nguyen J, Gupta V, Hebbel RP, Simone DA, Gupta K. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood 2010;116:456–65.PubMedCrossrefGoogle Scholar
[13]
Campbell CM, Carroll CP, Kiley K, Han D, HaywoodJr C, Lanzkron S, Swedberg L, Edwards RR, Page GG, Haythornthwaite JA. Quantitative sensory testing and pain-evoked cytokine reactivity:comparison of patients with sickle cell disease to healthy matched controls. Pain 2016;157:949–56.CrossrefPubMedGoogle Scholar
[14]
Campbell CM, Moscou-Jackson G, Carroll CP, Kiley K, Haywood Jr C, Lanzkron S, Hand M, Edwards RR, Haythornthwaite JA. An evaluation of central sensitization in patients with sickle cell disease. J Pain 2016;17:617–27.CrossrefPubMedGoogle Scholar
[15]
Darbari DS, Hampson JP, Ichesco E, Kadom N, Vezina G, Evangelou I, Clauw DJ, Taylor VI JG, Harris RE. Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease. J Pain 2015;16:1077–86.CrossrefPubMedGoogle Scholar
[16]
Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J, Fillingim RB, Maixner W, Geisslinge G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006;12:1269–77.CrossrefPubMedGoogle Scholar
[17]
Lotsch J, Klepstad P, Doehring A, Dale O. A GTP cyclohydrolase l genetic variant delays cancerpain. Pain 2010;148:103–6.CrossrefGoogle Scholar
[18]
Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA. Patients with sickle cell disease have increased sensitivity to cold and heat. Am J Hematol 2013;88:37–43.CrossrefPubMedGoogle Scholar
[19]
Cataldo G, Rajput S, Gupta K, Simone DA. Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease. Pain 2015;156:722–30.CrossrefGoogle Scholar
[20]
Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Pullum C, Schlaeger JM, Fillingim RB, Wilkie DJ. Safety and utility of quantitative sensory testing among adults with sickle cell disease: indicators of neuropathic pain? Pain Pract 2016;6:282–93.Google Scholar
[21]
Hillery CA, Kerstein PC, Vilceanu D, Barabas ME, Retherford D, Brandow AM, Wandersee NJ, Stucky CL. Transient receptor potential vanilloid l mediates pain in mice with severe sickle cell disease. Blood 2011;118:3376–83.CrossrefGoogle Scholar
[22]
Vincent L, Vang D, Nguyen J, Gupta M, Luk K, Ericson ME, Simone DA, Gupta K. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood 2013;122:1853–62.CrossrefPubMedGoogle Scholar
[23]
Woolf CJ. Central sensitization: implications forthe diagnosis and treatment of pain. Pain 2011;152:S2-15.CrossrefGoogle Scholar
[24]
Walk D, Sehgal N, Moeller-Bertram T, Edwards RR, Wasan A, Wallace M, Irving G, Argoff C, Backonja MM. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 2009;25:632–40.CrossrefPubMedGoogle Scholar
[25]
Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, Hansson P, Lautenbacher S, Marchand S, Wilder-Smith O. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain 2010;14:339.CrossrefPubMedGoogle Scholar
[26]
Garrison SR, Kramer AA, Gerges NZ, Hillery CA, Stucky CL. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors. Mol Pain 2012;8:62.PubMedGoogle Scholar
[27]
O’Leary JD, Crawford MW, Odame I, Shorten GD, McGrath PA. Thermal pain and sensory processing in children with sickle cell disease. Clin J Pain 2014;30:244–50.PubMedCrossrefGoogle Scholar
[28]
Jacob E, Chan VW, Hodge C, Zeltzer L, Zurakowski D, Sethna NF. Sensory and thermal quantitative testing inchildrenwith sickle cell disease. J PediatrHematol Oncol 2015;37:185–9.Google Scholar
[29]
Kenyon N, Wang L, Spornick N, Khaibullina A, Almeida LE, Cheng Y, Wang J, Guptill V, Finkel JC, Quezado ZM. Sickle cell disease in mice is associated with sensitization of sensory nerve fibers. Exp Biol Med (Maywood) 2015;240:87–98.PubMedCrossrefGoogle Scholar
[30]
Cain DM, Vang D, Simone DA, Hebbel RP, Gupta K. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol 2012;156:535–44.PubMedCrossrefGoogle Scholar
[31]
Zappia KJ, Garrison SR, Hillery CA, Stucky CL. Cold hypersensitivity increases with age in mice with sickle cell disease. Pain 2014;155:2476–85.PubMedCrossrefGoogle Scholar
[32]
Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK. Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain 2001;17:316-22.PubMedCrossrefGoogle Scholar
[33]
Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, Taylor LN, McLaughlin M, Brufsky A, Ahrendt G, Bovbjerg D, Edwards RR, Belfer I. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 2013;154:660–8.PubMedCrossrefGoogle Scholar
[34]
Gracely RH, McGrath F, Dubner R. Ratio scales of sensory and affective verbal paindescriptors. Pain 1978;5:5–18.CrossrefPubMedGoogle Scholar
[35]
Gracely RH, Kwilosz DM. The Descriptor Differential Scale: applying psychophysical principles to clinical pain assessment. Pain 1988;35:279–88.CrossrefPubMedGoogle Scholar
[36]
Gracely RH, Dubner R, McGrath PA. Fentanyl reduces the intensity of painful tooth pulp sensations: controlling for detection of active drugs. Anest Analg 1982;61:751-5.Google Scholar
[37]
Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Diatchenko L, Liu Q, Maixner W. Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain 2013;14.T63–74.el-6.PubMedCrossrefGoogle Scholar
[38]
Jaeger B, Reeves JL. Quantification of changes in myofascial trigger point sensitivity with the pressure algometer following passive stretch. Pain 1986;27:203–10.PubMedCrossrefGoogle Scholar
[39]
Kosek E, Ordeberg G. Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successfultreatment. EurJ Pain 2000;4:229–38.CrossrefGoogle Scholar
[40]
Carroll CP, Lanzkron S, Haywood Jr C, Kiley K, Pejsa M, Moscou-Jackson G, Haythornthwaite JA, Campbell CM. Chronic opioid therapy and central sensitization in sickle cell disease. AmJ Prev Med 2016;51:S69-77.CrossrefGoogle Scholar
[41]
Arendt-Nielsen L. Central sensitization in humans: assessment and pharmacology. Handb Exp Pharmacol 2015;227:79–102.PubMedCrossrefGoogle Scholar
[42]
Sato H, Saisu H, Muraoka W, Nakagawa T, Svensson P, Wajima K. Lackoftemporal summation but distinct aftersensations to thermal stimulation in patients with combined tension-type headache and myofascial temporomandibular disorder. J Orofac Pain 2012;26:288–95.PubMedGoogle Scholar
[43]
Schliessbach J, Siegenthaler A, Streitberger K, Eichenberger U, Nuesch E, Juni P, Arendt-Nielsen L, Curatolo M. The prevalence of widespread central hypersensitivity in chronic pain patients. Eur J Pain 2013;17:1502-10.PubMedGoogle Scholar
[44]
Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain 1999;79:75–82.CrossrefPubMedGoogle Scholar
[45]
Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441–51.CrossrefPubMedGoogle Scholar
[46]
Richards N, McMahon SB. Targeting novel peripheral mediators forthe treatment of chronic pain. Br J Anaesth 2013;111:46-51.CrossrefGoogle Scholar
[47]
King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley3rd JL. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain 2009;143:172–8.PubMedCrossrefGoogle Scholar
[48]
Campbell CM, France CR, Robinson ME, Logan HL, Geffken GR, Fillingim RB. Ethnic differences in diffuse noxious inhibitory controls. J Pain 2008;9:759–66.PubMedCrossrefGoogle Scholar
[49]
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639–44.CrossrefPubMedGoogle Scholar
[50]
Nagel RL, Fabry ME, Steinberg MH. The paradox of hemoglobin SCdisease. Blood Rev 2003;17:167–78.CrossrefPubMedGoogle Scholar
[51]
Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010;17:1010-8.PubMedCrossrefGoogle Scholar
[52]
Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570–87.CrossrefPubMedGoogle Scholar
[53]
Wang ZJ, Molokie RE, Wilkie DJ. Does cold hypersensitivity increase with age in sickle cell disease? Pain 2014;155:2439–40.PubMedCrossrefGoogle Scholar
[54]
Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000;88:69–78.CrossrefPubMedGoogle Scholar
Comments (0)